In a joint statement, the companies said data from roughly 36 individuals aged 55 years or older showed the booster dose led to a nearly four-fold increase in neutralizing antibody levels against the BA.4/5 variants after one month.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/FbU6vS7
0 Comments